Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Cochlear Ltd (CHEOY US)
Watchlist
6
Analysis
Health Care
•
Australia
Cochlear Limited researches, develops and markets cochlear implant systems for hearing impaired individuals. The Company's hearing implant systems include Nucleus and Baha and are sold both domestically and internationally.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Quantitative Analysis
•
26 Jun 2026 08:10
ASX Short Interest Weekly (Jun 19th): Aristocrat Leisure, Brambles, CSL, Regis Resources, Cochlear
We analyzed ASX short interest report for the past week and highlight short interest changes in Aristocrat Leisure, Brambles, CSL, Regis Resources,...
Ke Yan, CFA, FRM
Follow
101 Views
Share
bullish
•
Service Stream
•
25 Jun 2026 14:54
Quiddity Leaderboard ASX Sep26: Qube Deal Consequences + Many Other High-Impact Index Changes
All ASX 200 expected ADDs/DELs have fairly high-impact with multiple days of volume to trade. Most names have 6x-23x ADV to trade.
Janaghan Jeyakumar, CFA
Follow
196 Views
Share
bullish
•
MSCI ACWI Index
•
22 Nov 2019 05:57
Global Equity Strategy: Health Care Hitting On All Cylinders - Overweight
Global equities remain in a short-term consolidation phase, however we continue to believe the longer-term trend is up and to the right for the...
Vermilion Research
Follow
503 Views
Share
bullish
•
Cross Asset Strategy
•
20 Sep 2019 11:25
The Deadcat Bounce in Aussie Value
The Global rotation away from Defensive stocks to cyclical Growth and Value over the past few weeks has not been impressive enough to convince us...
Shane Lee
846 Views
Share
bullish
•
Cross Asset Strategy
•
29 Aug 2019 12:37
ASX Reporting Season Update: Misses and Downgrades Amongst Bright Spots
Reporting season has been relatively disappointing with only 45% of stocks able to either meet or beat FY19 expectations. Analyst expectations in...
Shane Lee
723 Views
Share
First
Previous
4
5
6
7
8
9
10
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x